Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: A case report

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Fasola, Gianpiero ^a   Puglisi, Fabio ^a   Follador, Alessandro ^a   Aita, Marianna ^a   Di Terlizzi, Silvia ^a   Belvedere, Ornella ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETININ; CORTICOSTEROID; CYANOCOBALAMIN; CYTOKERATIN 5; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; FINASTERIDE; FOLIC ACID; PEMETREXED; TERAZOSIN; VIMENTIN;

AGED; ANOREXIA; ARTICLE; CANCER PALLIATIVE THERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG FEVER; FATIGUE; GERIATRIC PATIENT; HOSPITAL ADMISSION; HUMAN; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; KARNOFSKY PERFORMANCE STATUS; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MALIGNANT MESOTHELIOMA; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PATIENT REFERRAL; PERITONEUM MESOTHELIOMA; PROSTATE HYPERTROPHY; SUBCUTANEOUS NODULE; TUMOR LOCALIZATION; TUMOR VOLUME; WEIGHT REDUCTION;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; GLUTAMATES; GUANINE; HUMANS; MALE; MESOTHELIOMA; PERITONEAL NEOPLASMS;

EID: 33846630877     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-289     Document Type: Article

References (8)

1. Britton M The epidemiology of mesothelioma Semin Oncol 2002 29 18-25 10.1053/sonc.2002.30237 11836665
2. Robinson BWS Musk AW Lake RA Malignant mesothelioma Lancet 2005 366 397-408 10.1016/S0140-6736(05)67025-0 16054941
3. Sugarbaker PH Welch LS Mohamed F Glehen O A review of peritoneal mesothelioma at the Washington Cancer Institute Surg Oncol Clin North Am 2003 12 3 605-621, xi 10.1016/S1055-3207(03)00045-0
4. Ordonez NG The immunohistochemical diagnosis of mesothelioma: A comparative study of epithelioid mesothelioma and lung adenocarcinoma Am J Surg Pathol 2003 27 8 1031-1051 10.1097/00000478-200308000-00001 12883236
5. Feldman AL Libutti SK Pingpank JF Bartlett DL Beresnev TH Mavroukakis SM Steinberg SM Liewehr DJ Kleiner DE Alexander HR Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy J Clin Oncol 2003 21 4560-4567 10.1200/JCO.2003.04.150 14673042
6. Scagliotti GV Shin DM Kindler HL Vasconcelles MJ Keppler U Manigold C Burris H Gatzemeier Blatter J Symanowski JT Rusthoven JJ Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma J Clin Oncol 2003 21 1556-1561 10.1200/JCO.2003.06.122 12697881
7. Vogelzang NJ Rusthoven JJ Symanowski J Denham C Kaukel E Ruffie P Gatzemeier U Boyer M Emri S Manegold C Niyikiza G Paoletti P Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma J Clin Oncol 2003 21 14 2636-44 10.1200/JCO.2003.11.136 12860938
8. Janne PA Wozniak AJ Belani CP Keohan ML Ross HJ Polikoff JA Mintzer DM Taylor R Ashland J Ye Z Monberg MJ Obasaju CK Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: Outcomes of an expanded access program Clin Lung Cancer 2005 7 40-46 16098243